Mineralys Therapeutics, Inc. (MLYS) PT Raised to $52 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts MLYS Hot Sheet
Price: $26.09 --0%
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 3
Join SI Premium – FREE
H.C. Wainwright analyst Matthew Caufield raised the price target on Mineralys Therapeutics, Inc. (NASDAQ: MLYS) to $52.00 (from $42.00) while maintaining a Buy rating.
You May Also Be Interested In
- Citi raises EquipmentShare price target to $22, keeps Neutral
- ITV Plc. (ITV:LN) (ITVPY) PT Lowered to GBP0.82 at JPMorgan
- Kopin Corp (KOPN) PT Raised to $6.50 at Canaccord
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
